FDA Inspection
ACS Dobfar SPAACS Dobfar SPA – FDA Inspection, Nov 23, 2023
Record Details
This FDA Inspection record concerns ACS Dobfar SPA, with an inspection on November 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 655df4a5-e416-415b-9b14-e4027dcc0160
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1264901
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of ACS Dobfar SPA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2018 | Not classified | Office of Inspections and Investigations | |
| November 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ACS Dobfar SPA
- FDA Inspection 1168950 - 2021-07-16
- FDA Inspection 1061908 - 2018-07-20
- FDA Inspection 951618 - 2015-11-13
- FDA Inspection 856325 - 2013-07-04
- FDA Inspection 667137 - 2010-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.